1. Home
  2. KOD

as 06-20-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Founded: 2009 Country:
United States
United States
Employees: N/A City: PALO ALTO
Market Cap: 188.9M IPO Year: 2018
Target Price: $9.00 AVG Volume (30 days): 294.1K
Analyst Decision: Hold Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.62 EPS Growth: N/A
52 Week Low/High: $1.92 - $11.60 Next Earning Date: 08-13-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

KOD Daily Stock ML Predictions

Stock Insider Trading Activity of Kodiak Sciences Inc (KOD)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
BORGESON JOHN A. KOD See Remarks Jun 15 '25 Sell $3.65 723 $2,639.67 183,316

Share on Social Networks: